RBREW Stock Analysis: Royal Unibrew | CO
Beverages - Brewers | CO, Denmark | Market Cap: 19.840m DKK | 12M Return: -11.3% | DK0060634707 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 65.1M
EPS Trend: 98.8%
Qual. Beats: 0
Rev. Trend: 92.8%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Royal Unibrew A/S is a Denmark-headquartered beverage company founded in 1901 (formerly Bryggerigruppen A/S, renamed in 2005) that produces, markets, and distributes a broad portfolio of drinks across more than a dozen European markets, including the Nordics, Germany, Italy, the Benelux, the Baltics, and France. Its offering spans soft drinks, energy drinks, bottled water, malt beverages, beer, ready-to-drink cocktails, ciders, juice, enhanced/sports drinks, and tea and coffee, supported by a large brand portfolio built through both organic development and acquisitions (e.g., Faxe, Ceres, Hansa, Lapin Kulta, Hartwall, Looza, and Vilkmerges).
Although classified under the Brewers sub-industry, Royal Unibrew operates a multi-category beverage model that uses its route-to-market and cold-chain logistics across the Nordics and other regions to sell non-beer categories alongside its beer brands, a strategy that diversifies revenue away from cyclical beer consumption and leverages shared distribution scale. Its geographic footprint extends well beyond its Danish home market, making it a regional consolidator in the Northern European beverage space.
- Energy drink and RTD portfolio drives Nordic volume growth
- Input cost inflation pressures beer and soft drink margins
- M&A pipeline targets bolt-on beverage acquisitions in Europe
| Net Income: 1.61b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 1.55 > 1.0 |
| NWC/Revenue: -13.70% < 20% (prev -13.32%; Δ -0.38% < -1%) |
| CFO/TA 0.12 > 3% & CFO 2.33b > Net Income 1.61b |
| Net Debt (6.61b) to EBITDA (2.86b): 2.31 < 3 |
| Current Ratio: 0.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (48.8m) vs 12m ago -2.36% < -2% |
| Gross Margin: 43.49% > 18% (prev 42.71%; Δ 0.78% > 0.5%) |
| Asset Turnover: 82.75% > 50% (prev 80.69%; Δ 2.06% > 0%) |
| Interest Coverage Ratio: 8.11 > 6 (EBIT TTM 2.09b / Interest Expense TTM 258.0m) |
| A: -0.11 (Total Current Assets 4.22b - Total Current Liabilities 6.39b) / Total Assets 19.3b |
| B: 0.24 (Retained Earnings 4.63b / Total Assets 19.3b) |
| C: 0.11 (EBIT TTM 2.09b / Avg Total Assets 19.1b) |
| D: 0.48 (Book Value of Equity 6.21b / Total Liabilities 13.1b) |
| Altman-Z'' = 1.28 = BB |
| DSRI: 0.99 (Receivables 2.46b/2.39b, Revenue 15.8b/15.3b) |
| GMI: 0.98 (GM 42.71% / 43.49%) |
| AQI: 0.99 (AQ_t 0.51 / AQ_t-1 0.51) |
| SGI: 1.03 (Revenue 15.8b / 15.3b) |
| TATA: -0.04 (NI 1.61b - CFO 2.33b) / TA 19.3b) |
| Beneish M = -3.03 (Cap -4..+1) = AA |
As of September 08, 2026, the stock is trading at DKK 414.20 with a total of 116,416 shares traded. Over the past week, the price has changed by -3.22%, over one month by -14.10%, over three months by +1.17% and over the past year by -11.33%.
Current recommended Stop Loss: 398.90 (which is 3.7% or 1.8 ATR below the current price).
Royal Unibrew has no consensus analysts rating.
P/E Trailing = 12.7929
P/E Forward = 11.325
P/S = 1.2544
P/B = 3.234
P/EG = 6.2944
Revenue TTM = 15.8b DKK
EBIT TTM = 2.09b DKK
EBITDA TTM = 2.86b DKK
Long Term Debt = 5.43b DKK (from longTermDebt, last fiscal year)
Short Term Debt = 1.28b DKK (from shortTermDebt, last quarter)
Debt = 6.66b DKK (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.61b DKK (calculated: Debt 6.66b - CCE 54.0m)
Enterprise Value = 26.4b DKK (19.8b + Debt 6.66b - CCE 54.0m)
Interest Coverage Ratio = 8.11 (Ebit TTM 2.09b / Interest Expense TTM 258.0m)
EV/FCF = 16.79x (Enterprise Value 26.4b / FCF TTM 1.57b)
FCF Yield = 5.95% (FCF TTM 1.57b / Enterprise Value 26.4b)
FCF Margin = 9.96% (FCF TTM 1.57b / Revenue TTM 15.8b)
Net Margin = 10.19% (Net Income TTM 1.61b / Revenue TTM 15.8b)
Gross Margin = 43.49% ((Revenue TTM 15.8b - Cost of Revenue TTM 8.94b) / Revenue TTM)
Gross Margin QoQ = 46.16% (prev 40.59%)
Tobins Q-Ratio = 1.37 (Enterprise Value 26.4b / Total Assets 19.3b)
Interest Expense / Debt = 3.87% (Interest Expense 258.0m / Debt 6.66b)
Taxrate = 20.64% (419.0m / 2.03b)
NOPAT = 1.66b (EBIT 2.09b * (1 - 20.64%))
Current Ratio = 0.66 (Total Current Assets 4.22b / Total Current Liabilities 6.39b)
Debt / Equity = 1.07 (Debt 6.66b / totalStockholderEquity, last quarter 6.21b)
Debt / EBITDA = 2.31 (Net Debt 6.61b / EBITDA 2.86b)
Debt / FCF = 4.20 (Net Debt 6.61b / FCF TTM 1.57b)
Total Stockholder Equity = 6.59b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.43% (Net Income 1.61b / Total Assets 19.3b)
RoE = 24.45% (Net Income TTM 1.61b / Total Stockholder Equity 6.59b)
RoCE = 17.41% (EBIT 2.09b / Capital Employed (Equity 6.59b + L.T.Debt 5.43b))
RoIC = 11.78% (NOPAT 1.66b / Invested Capital 14.1b)
WACC = 4.51% (E(19.8b)/V(26.5b) * Re(4.99%) + D(6.66b)/V(26.5b) * Rd(3.87%) * (1-Tc(0.21)))
Discount Rate = 4.99% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -70.77 | Cagr: -1.06%
[DCF] Terminal Value 77.97% ; FCFF base≈1.45b ; Y1≈1.66b ; Y5≈2.44b
[DCF] Fair Price = 635.3 (EV 36.7b - Net Debt 6.61b = Equity 30.1b / Shares 47.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.84 | EPS CAGR: 18.86% | SUE: -0.53 | # QB: 0
Revenue Correlation: 92.78 | Revenue CAGR: 8.99% | SUE: 0.57 | # QB: 0
EPS current Quarter (2026-09-30): EPS=12.22 | Chg30d=+1.71% | Revisions=+25% | Analysts=5
EPS current Year (2026-12-31): EPS=34.17 | Chg30d=-0.78% | Revisions=+29% | GrowthEPS=+9.2% | GrowthRev=+0.8%
EPS next Year (2027-12-31): EPS=37.69 | Chg30d=-0.83% | Revisions=+0% | GrowthEPS=+10.3% | GrowthRev=+3.6%
[Analyst] Revisions Ratio: +25% (up=6, down=3)